Sylvain Chemtob Selected Research

copper bis(3,5-diisopropylsalicylate)

12/2004

Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvain Chemtob Research Topics

Disease

34	Inflammation (Inflammations) 05/2022 - 02/2003
16	Premature Birth (Birth, Premature) 01/2022 - 07/2015
16	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021 - 07/2002
14	Hyperoxia 01/2021 - 07/2002
8	Ischemia 01/2022 - 02/2006
8	Premature Obstetric Labor (Premature Labor) 01/2019 - 12/2002
8	Hypercapnia 06/2010 - 05/2002
7	Hypoxia (Hypoxemia) 12/2016 - 03/2009
7	Retinal Neovascularization 01/2016 - 04/2006
6	Choroidal Neovascularization 11/2019 - 05/2011
5	Pathologic Neovascularization 01/2022 - 07/2011
5	Retinal Degeneration 11/2020 - 10/2007
5	Neoplasms (Cancer) 01/2019 - 10/2003
4	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 10/2007
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2016 - 05/2008
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2005
3	Brain Injuries (Brain Injury) 09/2020 - 10/2008
3	Infections 01/2020 - 10/2015
3	Platelet Glycoprotein IV Deficiency 01/2019 - 02/2008
2	Neuroinflammatory Diseases 05/2022 - 04/2021
2	Infarction (Infarctions) 01/2022 - 02/2014
2	Pregnancy Complications 12/2020 - 12/2016
2	Blindness (Hysterical Blindness) 01/2020 - 12/2016
2	Triple Negative Breast Neoplasms 01/2019 - 02/2018
2	Rheumatoid Arthritis 01/2019 - 11/2014
2	Atrophy 01/2017 - 02/2008
2	Wounds and Injuries (Trauma) 01/2017 - 08/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2016 - 11/2014
2	Ganglion Cysts (Ganglion) 08/2013 - 10/2008
2	Corneal Neovascularization 03/2012 - 05/2009
2	Patent Ductus Arteriosus 06/2011 - 10/2004
2	Hepatocellular Carcinoma (Hepatoma) 06/2006 - 10/2003
2	Retinal Vein Occlusion 05/2005 - 01/2005
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 04/2003 - 03/2003
1	Eye Diseases (Eye Disease) 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2021
1	Fetal Weight 01/2021
1	Chorioamnionitis 01/2021
1	Birth Weight (Birth Weights) 12/2020
1	Hyperglycemia 12/2020
1	Central Nervous System Diseases (CNS Diseases) 09/2020
1	Brain Neoplasms (Brain Tumor) 09/2020
1	Glioma (Gliomas) 09/2020

Drug/Important Bio-Agent (IBA)

38	Retinaldehyde (Retinal)IBA 01/2022 - 05/2002
16	Oxygen (Dioxygen)IBA 12/2020 - 07/2002
10	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 10/2008
7	Interleukin-1 (Interleukin 1)IBA 05/2022 - 10/2008
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2008
6	LipopolysaccharidesIBA 05/2022 - 08/2010
6	LipidsIBA 01/2022 - 08/2002
6	CytokinesIBA 01/2021 - 04/2016
6	ProstaglandinsIBA 01/2019 - 05/2002
5	Peptides (Polypeptides)IBA 01/2020 - 10/2008
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
5	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 05/2013
5	Succinic Acid (Succinate)IBA 02/2014 - 10/2008
4	101.10 peptideIBA 01/2022 - 10/2008
4	InterleukinsIBA 01/2022 - 04/2016
4	Tocolytic Agents (Tocolytics)IBA 01/2021 - 09/2011
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2020 - 10/2008
4	LigandsIBA 01/2019 - 10/2006
4	lysophosphatidic acidIBA 03/2009 - 10/2003
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2007 - 05/2002
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
3	Interleukin-12 (IL 12)IBA 01/2019 - 01/2014
3	Scavenger Receptors (Scavenger Receptor)IBA 01/2019 - 02/2008
3	Interleukin-23 (Interleukin 23)IBA 04/2016 - 01/2014
3	Semaphorin-3AIBA 02/2015 - 08/2012
3	oxidized low density lipoproteinIBA 06/2013 - 10/2006
2	Pharmaceutical PreparationsIBA 06/2021 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2021 - 03/2009
2	KininsIBA 09/2020 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2017
2	Amino Acids FDA Link 01/2019 - 09/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2017 - 12/2002
2	A-factor (Streptomyces)IBA 11/2017 - 09/2017
2	EndotoxinsIBA 01/2017 - 12/2002
2	platelet activating factor receptorIBA 01/2016 - 01/2016
2	Semaphorins (Semaphorin)IBA 08/2012 - 01/2011
2	GS 101IBA 03/2012 - 05/2009
2	Arachidonic AcidsIBA 01/2011 - 02/2010
2	DinoprostIBA 08/2010 - 03/2003
2	Arachidonic Acid (Vitamin F)IBA 11/2007 - 06/2006
2	Platelet Activating FactorIBA 03/2006 - 01/2005
2	Dinoprostone (PGE2)FDA Link 02/2006 - 10/2004
2	Oxidants (Oxidizing Agents)IBA 08/2004 - 04/2003
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	AminesIBA 01/2021
1	Surface-Active Agents (Surfactants)IBA 12/2020
1	Blood Glucose (Blood Sugar)IBA 12/2020
1	Insulin (Novolin)FDA Link 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2020
1	VaccinesIBA 01/2020

Therapy/Procedure

7	Therapeutics 06/2021 - 03/2012
4	Lasers (Laser) 11/2016 - 10/2007
2	Injections 01/2016 - 03/2006
1	Catheters 01/2021
1	Duration of Therapy 12/2020